Symbols / BTCY $0.25 +2.98% Biotricity, Inc.

Healthcare • Medical Devices • United States • OQB
BTCY Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Waqaas Al-Siddiq Ph.D.
Exch · Country OQB · United States
Market Cap 7.01M
Enterprise Value 35.83M
Income -4.70M
Sales 15.45M
FCF (ttm) 379.27K
Book/sh -1.22
Cash/sh 0.05
Employees 46
Insider 10d —
IPO Feb 19, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.57
PEG —
P/S 0.45
P/B -0.20
P/C —
EV/EBITDA 243.48
EV/Sales 2.32
Quick Ratio 0.13
Current Ratio 0.21
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -0.16
EPS next Y -0.43
EPS Growth —
Revenue Growth 10.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-06-25
Earnings (prior) 2025-11-14
ROA 1.51%
ROE —
ROIC —
Gross Margin 81.09%
Oper. Margin 11.06%
Profit Margin -25.99%
Shs Outstand 28.44M
Shs Float 16.65M
Insider Own 36.76%
Instit Own 1.79%
Short Float 2.25%
Short Ratio 5.50
Short Interest 459.95K
52W High 0.75
vs 52W High -67.48%
52W Low 0.20
vs 52W Low 22.55%
Beta 1.31
Impl. Vol. —
Rel Volume 0.90
Avg Volume 37.67K
Volume 33.91K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.24
Price $0.25
Change 2.98%
About

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.25
Latest analyst target
3. DCF / Fair value
$0.24
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.25
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-11-18 reit HC Wainwright & Co. — → Neutral —
2023-11-20 down HC Wainwright & Co. Buy → Neutral —
2023-07-05 reit HC Wainwright & Co. Buy → Buy $4
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
13.79
+14.32%
12.06
+25.15%
9.64
+26.00%
7.65
Operating Revenue
13.79
+14.32%
12.06
+25.15%
9.64
+26.00%
7.65
Cost Of Revenue
3.23
-12.98%
3.71
-11.67%
4.20
+36.26%
3.08
Reconciled Cost Of Revenue
3.23
-12.98%
3.71
-11.67%
4.20
+36.26%
3.08
Gross Profit
10.56
+26.43%
8.36
+53.55%
5.44
+19.08%
4.57
Operating Expense
13.01
-24.27%
17.18
-17.59%
20.85
-2.14%
21.31
Research And Development
2.16
-16.18%
2.57
-20.37%
3.23
+17.68%
2.74
Selling General And Administration
10.86
-25.70%
14.61
-17.08%
17.62
-5.07%
18.56
General And Administrative Expense
10.86
-25.70%
14.61
-17.08%
17.62
-5.07%
18.56
Other Gand A
10.86
-25.70%
14.61
-17.08%
17.62
-5.07%
18.56
Total Expenses
16.24
-22.27%
20.89
-16.60%
25.05
+2.71%
24.39
Operating Income
-2.45
+72.26%
-8.83
+42.71%
-15.41
+7.93%
-16.74
Total Operating Income As Reported
-2.45
+72.26%
-8.83
+42.71%
-15.41
—
EBITDA
-3.21
+63.88%
-8.90
+44.64%
-16.07
+13.41%
-18.56
Normalized EBITDA
-2.66
+70.14%
-8.91
+42.86%
-15.59
+12.81%
-17.88
Reconciled Depreciation
0.01
+0.00%
0.01
+0.00%
0.01
+157.93%
0.00
EBIT
-3.22
+63.84%
-8.90
+44.62%
-16.08
+13.39%
-18.56
Total Unusual Items
-0.55
-5764.89%
0.01
+102.02%
-0.48
+29.21%
-0.68
Total Unusual Items Excluding Goodwill
-0.55
-5764.89%
0.01
+102.02%
-0.48
+29.21%
-0.68
Net Income
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Pretax Income
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Net Non Operating Interest Income Expense
-5.20
-0.20%
-5.19
-101.03%
-2.58
+75.57%
-10.57
Interest Expense Non Operating
5.20
+0.20%
5.19
+101.03%
2.58
-75.57%
10.57
Net Interest Income
-5.20
-0.20%
-5.19
-101.03%
-2.58
+75.57%
-10.57
Interest Expense
5.20
+0.20%
5.19
+101.03%
2.58
-75.57%
10.57
Other Income Expense
-0.77
-936.95%
-0.07
+88.84%
-0.67
+63.50%
-1.82
Other Non Operating Income Expenses
-0.22
-157.53%
-0.08
+53.79%
-0.18
+84.05%
-1.14
Gain On Sale Of Security
-0.55
-5764.89%
0.01
+102.02%
-0.48
+29.21%
-0.68
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Net Income From Continuing Operation Net Minority Interest
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Net Income From Continuing And Discontinued Operation
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Net Income Continuous Operations
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Normalized Income
-7.87
+44.22%
-14.10
+22.40%
-18.17
+36.11%
-28.45
Net Income Common Stockholders
-11.94
+20.01%
-14.93
+23.57%
-19.53
+35.36%
-30.22
Otherunder Preferred Stock Dividend
3.05
0.00
—
—
Diluted EPS
-0.56
+66.57%
-1.66
+26.42%
-2.26
+43.46%
-3.99
Basic EPS
-0.56
+66.57%
-1.66
+26.42%
-2.26
+43.46%
-3.99
Basic Average Shares
21.52
+139.38%
8.99
+3.83%
8.66
+14.32%
7.57
Diluted Average Shares
21.52
+139.38%
8.99
+3.83%
8.66
+14.32%
7.57
Diluted NI Availto Com Stockholders
-11.94
+20.01%
-14.93
+23.57%
-19.53
+35.36%
-30.22
Preferred Stock Dividends
0.47
-44.15%
0.83
-4.67%
0.88
-19.60%
1.09
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
5.64
-5.08%
5.94
-8.72%
6.51
-60.96%
16.68
Current Assets
4.64
+3.77%
4.47
-5.29%
4.72
-69.19%
15.32
Cash Cash Equivalents And Short Term Investments
0.37
-53.55%
0.79
+37.79%
0.57
-95.27%
12.07
Cash And Cash Equivalents
0.37
-53.55%
0.79
+37.79%
0.57
-95.27%
12.07
Cash Financial
0.37
-53.55%
0.79
+37.79%
0.57
-95.27%
12.07
Receivables
2.72
+50.61%
1.81
-0.42%
1.81
-24.87%
2.41
Accounts Receivable
1.66
+12.94%
1.47
+19.97%
1.22
-39.00%
2.01
Other Receivables
1.06
+215.05%
0.34
-42.84%
0.59
+44.88%
0.41
Inventory
1.56
-17.24%
1.88
-19.58%
2.34
+177.25%
0.84
Raw Materials
1.23
+8.59%
1.13
-4.89%
1.19
+153.33%
0.47
Finished Goods
0.33
-56.08%
0.75
-34.74%
1.15
+207.17%
0.37
Prepaid Assets
—
—
—
0.41
Total Non Current Assets
1.00
-31.95%
1.47
-17.78%
1.79
+32.11%
1.36
Net PPE
0.82
-33.58%
1.24
-23.11%
1.61
+26.68%
1.27
Gross PPE
0.84
-32.73%
1.25
-22.62%
1.62
+27.10%
1.27
Accumulated Depreciation
-0.02
-41.88%
-0.01
-72.05%
-0.01
-257.97%
-0.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Other Properties
0.81
-33.53%
1.22
-23.05%
1.59
+27.75%
1.24
Leases
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Non Current Accounts Receivable
0.07
-52.83%
0.15
+55.60%
0.10
—
Non Current Prepaid Assets
0.11
+28.58%
0.09
+0.00%
0.09
+0.00%
0.09
Total Liabilities Net Minority Interest
35.66
-0.74%
35.92
+36.29%
26.36
+40.02%
18.82
Current Liabilities
20.64
-9.09%
22.70
+103.38%
11.16
+129.32%
4.87
Payables And Accrued Expenses
7.64
-20.38%
9.59
+90.22%
5.04
+94.26%
2.60
Payables
4.60
-11.87%
5.22
+52.02%
3.44
+196.26%
1.16
Accounts Payable
4.60
-11.87%
5.22
+52.02%
3.44
+196.26%
1.16
Current Accrued Expenses
3.03
-30.56%
4.37
+171.85%
1.61
+11.91%
1.44
Current Debt And Capital Lease Obligation
12.55
+3.77%
12.09
+136.67%
5.11
+191.95%
1.75
Current Debt
12.02
+3.29%
11.64
+143.72%
4.77
+210.03%
1.54
Other Current Borrowings
12.02
+3.29%
11.64
+143.72%
4.77
+210.03%
1.54
Current Capital Lease Obligation
0.53
+16.16%
0.46
+36.28%
0.34
+59.57%
0.21
Current Deferred Liabilities
0.03
+17.50%
0.02
0.00
—
Current Deferred Revenue
0.03
+17.50%
0.02
0.00
—
Other Current Liabilities
0.42
-57.23%
0.99
-1.62%
1.01
+93.61%
0.52
Total Non Current Liabilities Net Minority Interest
15.02
+13.60%
13.22
-12.99%
15.20
+8.88%
13.96
Long Term Debt And Capital Lease Obligation
13.54
+14.89%
11.78
-18.36%
14.44
+6.12%
13.60
Long Term Debt
13.14
+21.06%
10.86
-16.81%
13.05
+4.54%
12.48
Long Term Capital Lease Obligation
0.40
-57.18%
0.93
-32.99%
1.39
+23.79%
1.12
Stockholders Equity
-30.01
-0.12%
-29.98
-51.05%
-19.85
-825.31%
-2.14
Common Stock Equity
-32.01
-1.74%
-31.47
-58.55%
-19.85
-825.30%
-2.14
Capital Stock
2.03
+35.24%
1.50
+17005.50%
0.01
-82.92%
0.05
Common Stock
0.03
+175.81%
0.01
+8.71%
0.01
-82.93%
0.05
Preferred Stock
2.00
+34.34%
1.49
+21270285.71%
0.00
-12.50%
0.00
Share Issued
26.24
+175.81%
9.51
+8.71%
8.75
+2.41%
8.55
Ordinary Shares Number
26.24
+175.81%
9.51
+8.71%
8.75
+2.41%
8.55
Additional Paid In Capital
106.97
+11.75%
95.72
+3.10%
92.84
+1.46%
91.51
Retained Earnings
-139.44
-9.37%
-127.50
-13.26%
-112.57
-21.00%
-93.04
Gains Losses Not Affecting Retained Earnings
0.15
+350.28%
0.03
+121.19%
-0.15
+80.12%
-0.77
Other Equity Adjustments
0.15
+350.28%
0.03
+121.19%
-0.15
+80.12%
-0.77
Total Equity Gross Minority Interest
-30.01
-0.12%
-29.98
-51.05%
-19.85
-825.31%
-2.14
Total Capitalization
-16.87
+11.76%
-19.12
-181.37%
-6.80
-165.73%
10.34
Working Capital
-16.00
+12.24%
-18.23
-183.02%
-6.44
-161.60%
10.46
Invested Capital
-6.85
+23.63%
-8.97
-343.94%
-2.02
-117.02%
11.88
Total Debt
26.09
+9.26%
23.88
+22.17%
19.55
+27.31%
15.35
Net Debt
24.80
+14.23%
21.71
+25.81%
17.25
+781.84%
1.96
Capital Lease Obligations
0.93
-32.99%
1.39
-19.49%
1.72
+29.45%
1.33
Net Tangible Assets
-30.01
-0.12%
-29.98
-51.05%
-19.85
-825.31%
-2.14
Tangible Book Value
-32.01
-1.74%
-31.47
-58.55%
-19.85
-825.30%
-2.14
Derivative Product Liabilities
1.48
+3.00%
1.44
+89.14%
0.76
+115.40%
0.35
Other Equity Interest
0.28
+5.64%
0.27
+976.30%
0.02
-75.56%
0.10
Preferred Stock Equity
2.00
+34.34%
1.49
+21270285.71%
0.00
-12.50%
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-2.38
+64.44%
-6.69
+50.59%
-13.55
+10.65%
-15.16
Cash Flow From Continuing Operating Activities
-2.38
+64.44%
-6.69
+50.59%
-13.55
+10.65%
-15.16
Net Income From Continuing Operations
-8.42
+40.25%
-14.09
+24.46%
-18.66
+35.95%
-29.13
Depreciation Amortization Depletion
0.01
+0.00%
0.01
+0.00%
0.01
+157.93%
0.00
Depreciation
0.01
+0.00%
0.01
+0.00%
0.01
+157.93%
0.00
Depreciation And Amortization
0.01
+0.00%
0.01
+0.00%
0.01
+157.93%
0.00
Other Non Cash Items
3.06
+13.42%
2.70
+61.99%
1.66
-86.67%
12.49
Stock Based Compensation
1.46
+42.48%
1.03
+58.41%
0.65
-29.11%
0.91
Operating Gains Losses
0.55
+5764.89%
-0.01
-102.02%
0.48
-29.21%
0.68
Gain Loss On Investment Securities
0.55
+5764.89%
-0.01
-102.02%
0.48
-29.21%
0.68
Change In Working Capital
0.96
-73.87%
3.68
+59.51%
2.31
+2063.52%
-0.12
Change In Receivables
-0.11
+62.81%
-0.30
-143.46%
0.69
+257.57%
-0.44
Changes In Account Receivables
-0.11
+62.81%
-0.30
-143.46%
0.69
+257.57%
-0.44
Change In Inventory
0.32
-29.19%
0.46
+130.63%
-1.49
-161.92%
-0.57
Change In Prepaid Assets
-0.75
-396.59%
0.25
+212.15%
-0.22
-270.59%
-0.06
Change In Payables And Accrued Expense
1.50
-54.24%
3.27
-2.10%
3.34
+252.11%
0.95
Investing Cash Flow
—
—
0.00
+100.00%
-0.03
Cash Flow From Continuing Investing Activities
—
—
0.00
+100.00%
-0.03
Net PPE Purchase And Sale
—
—
0.00
+100.00%
-0.03
Purchase Of PPE
—
—
0.00
+100.00%
-0.03
Capital Expenditure
—
—
—
-0.03
Financing Cash Flow
1.93
-71.38%
6.74
+236.81%
2.00
-92.05%
25.17
Cash Flow From Continuing Financing Activities
1.93
-71.38%
6.74
+236.81%
2.00
-92.05%
25.17
Net Issuance Payments Of Debt
0.10
-97.34%
3.82
-0.42%
3.83
-63.84%
10.60
Issuance Of Debt
1.83
-38.06%
2.96
+25.77%
2.36
-80.78%
12.26
Repayment Of Debt
—
—
—
-1.66
Long Term Debt Issuance
1.83
-38.06%
2.96
+25.77%
2.36
-80.78%
12.26
Net Long Term Debt Issuance
1.83
-38.06%
2.96
+25.77%
2.36
-80.78%
12.26
Short Term Debt Issuance
—
—
3.83
0.00
Short Term Debt Payments
—
—
—
-1.66
Net Short Term Debt Issuance
-1.73
-303.22%
0.85
-42.21%
1.48
+188.91%
-1.66
Net Common Stock Issuance
0.13
+4.98%
0.12
0.00
-100.00%
14.80
Cash Dividends Paid
-0.03
-66.43%
-0.02
+98.10%
-0.95
+2.00%
-0.97
Repurchase Of Capital Stock
—
0.00
+100.00%
-0.90
-289.37%
-0.23
Proceeds From Stock Option Exercised
—
0.00
-100.00%
0.01
-98.57%
0.87
Changes In Cash
-0.45
-1043.88%
0.05
+100.41%
-11.55
-215.75%
9.98
Effect Of Exchange Rate Changes
0.03
-82.12%
0.17
+236.58%
0.05
+145.45%
-0.11
Beginning Cash Position
0.79
+37.79%
0.57
-95.27%
12.07
+448.11%
2.20
End Cash Position
0.37
-53.55%
0.79
+37.79%
0.57
-95.27%
12.07
Free Cash Flow
-2.38
+64.44%
-6.69
+50.59%
-13.55
+10.83%
-15.19
Interest Paid Supplemental Data
3.61
+78.61%
2.02
+24.83%
1.62
+192.81%
0.55
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
0.13
+4.98%
0.12
0.00
-100.00%
14.80
Issuance Of Capital Stock
1.86
-36.90%
2.94
0.00
-100.00%
14.90
Net Preferred Stock Issuance
1.73
-38.67%
2.83
+415.45%
-0.90
-588.89%
-0.13
Preferred Stock Dividend Paid
-0.03
-66.43%
-0.02
+98.10%
-0.95
+2.00%
-0.97
Preferred Stock Issuance
1.73
-38.67%
2.83
0.00
-100.00%
0.10
Preferred Stock Payments
—
0.00
+100.00%
-0.90
-289.37%
-0.23
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category